Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tanner

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Blood Advances|July 19, 2024
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron B Boothby, Matthew K Tanner, Abdullah Alswied, et al.
Journal of Hospital Medicine|June 1, 2025
Pediatric nurse perspectives on patient- and family-centered rounds: A qualitative studyJennifer Baird, Genevieve Beaird, Elizabeth K Tanner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2015
Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumesMichelle C Carlson, Julie H Kuo, Yi-Fang Chuang, et al.
Communications Medicine|January 18, 2025
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Blood Advances|July 19, 2024
Cumulative donor-specific antibody threshold predicts platelet transfusion response in HLA-alloimmunized patientsAaron B Boothby, Matthew K Tanner, Abdullah Alswied, et al.
Journal of Hospital Medicine|June 1, 2025
Pediatric nurse perspectives on patient- and family-centered rounds: A qualitative studyJennifer Baird, Genevieve Beaird, Elizabeth K Tanner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2015
Impact of the Baltimore Experience Corps Trial on cortical and hippocampal volumesMichelle C Carlson, Julie H Kuo, Yi-Fang Chuang, et al.
Communications Medicine|January 18, 2025
FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Tyler Picariello, Brendan Quinn, et al.
The Lancet. Neurology|February 21, 2023
Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trialCharles A Thornton, Richard Thomas Moxley, Katy Eichinger, et al.
Pageof 18